Stepwise approach towards adoption of allergen immunotherapy for allergic rhinitis and asthma patients in daily practice in Belgium: a BelSACI-Abeforcal-EUFOREA statement
暂无分享,去创建一个
J. Bousquet | C. Bachert | P. Hellings | P. Gevaert | V. Hox | B. Pugin | S. Seys | P. Rombaux | J. Ceuppens | J. Watelet | O. Vanderveken | D. Bullens | C. Breynaert | R. Schrijvers | K. Ladha | D. Ebo | S. Vlaminck | L. Van Gerven | L. V. Gerven | G. Marien | X. Van der Brempt | B. Verhaeghe | G. Mariën | G. Clement | T. Cox | S. Halewyck | R. Jacobs | K. Speleman | K. Vierstraete | Claus Bachert | X. Brempt | Philippe Rombaux | V. Hox | Jan Ceuppens | S. Seys | D. G. Ebo | J. Bousquet | P. Hellings | B. Pugin | Rik Schrijvers | Christine Breynaert
[1] J. Bousquet,et al. Aligning the Good Practice MASK With the Objectives of the European Innovation Partnership on Active and Healthy Ageing , 2020, Allergy, asthma & immunology research.
[2] C. Bachert,et al. Real‐world benefits of allergen immunotherapy for birch pollen‐associated allergic rhinitis and asthma , 2018, Allergy.
[3] Boleslaw Samolinski,et al. Electronic Clinical Decision Support System for allergic rhinitis management: MASK e‐CDSS , 2018, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[4] J. Bousquet,et al. Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management , 2018, Clinical and Translational Allergy.
[5] O. Usmani,et al. Addressing the Impact and Unmet Needs of Nonadherence in Asthma and Chronic Obstructive Pulmonary Disease: Where Do We Go From Here? , 2018, The journal of allergy and clinical immunology. In practice.
[6] A. Sheikh,et al. Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapy , 2018, Allergy.
[7] A. Sheikh,et al. EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis , 2018, Allergy.
[8] A. Sheikh,et al. Health economic analysis of allergen immunotherapy for the management of allergic rhinitis, asthma, food allergy and venom allergy: A systematic overview , 2018, Allergy.
[9] A. Sheikh,et al. The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study , 2018, Allergy.
[10] P. Cullinan,et al. Impact of Rhinitis on Work Productivity: A Systematic Review. , 2017, The journal of allergy and clinical immunology. In practice.
[11] A. Sheikh,et al. The Work Productivity and Activity Impairment Allergic Specific (WPAI-AS) Questionnaire Using Mobile Technology: The MASK Study. , 2017, Journal of investigational allergology & clinical immunology.
[12] E. Valovirta,et al. Results from the 5‐year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy , 2017, The Journal of allergy and clinical immunology.
[13] A. Leunig,et al. Rhinology Future Debates, an EUFOREA Report. , 2017, Rhinology.
[14] J. Bousquet,et al. Non‐allergic rhinitis: Position paper of the European Academy of Allergy and Clinical Immunology , 2017, Allergy.
[15] J. Bousquet,et al. Work productivity in rhinitis using cell phones: The MASK pilot study , 2017, Allergy.
[16] Joaquim Mullol,et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision , 2017, The Journal of allergy and clinical immunology.
[17] D. Ryan,et al. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement , 2017, Allergy.
[18] W. Fokkens,et al. Endotype-driven treatment in chronic upper airway diseases , 2017, Clinical and Translational Allergy.
[19] John Appleby,et al. A Terrible Beauty: A short history of NICE the National Institute for Health and Care Excellence , 2017 .
[20] P Demoly,et al. Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK‐rhinitis study , 2017, Allergy.
[21] J. Bousquet,et al. The Finnish Allergy Programme 2008–2018 works , 2017, European Respiratory Journal.
[22] A. Sheikh,et al. Allergen immunotherapy for allergic asthma: A systematic review and meta‐analysis , 2017, Allergy.
[23] A. Leunig,et al. Rhinology Future Debates, an EUFOREA Report. , 2017, Rhinology.
[24] P. Hellings,et al. Real-life study showing better control of allergic rhinitis by immunotherapy than regular pharmacotherapy. , 2017, Rhinology.
[25] Todor A Popov,et al. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis. , 2016, The Journal of allergy and clinical immunology.
[26] J. Bousquet,et al. MP‐AzeFlu is more effective than fluticasone propionate for the treatment of allergic rhinitis in children , 2016, Allergy.
[27] J. Bousquet,et al. AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation , 2016, European Respiratory Journal.
[28] A. Sheikh,et al. Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review , 2016, Clinical and Translational Allergy.
[29] L. Cardell,et al. TOTALL: high cost of allergic rhinitis—a national Swedish population-based questionnaire study , 2016, npj Primary Care Respiratory Medicine.
[30] S. Simoens,et al. Economic burden of inadequate management of allergic diseases in the European Union: a GA2LEN review , 2014, Allergy.
[31] G. Liss,et al. AAAAI/ACAAI surveillance study of subcutaneous immunotherapy, years 2008-2012: an update on fatal and nonfatal systemic allergic reactions. , 2014, The journal of allergy and clinical immunology. In practice.
[32] P. Rombaux,et al. Nationwide survey on immunotherapy practice by ENT specialists. , 2014, Rhinology.
[33] N. Papadopoulos,et al. Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology , 2013, Allergy.
[34] J. Bousquet,et al. Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today? , 2013, Allergy.
[35] C. Bachert,et al. Prevalence of Allergic Sensitization versus Allergic Rhinitis Symptoms in an Unselected Population , 2012, International Archives of Allergy and Immunology.
[36] G. Scadding,et al. Nasal corticosteroid treatment reduces substance P levels in tear fluid in allergic rhinoconjunctivitis. , 2012, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[37] P. Hellings,et al. Explorative study on patient’s perceived knowledge level, expectations, preferences and fear of side effects for treatment for allergic rhinitis , 2012, Clinical and Translational Allergy.
[38] Glenis K Scadding,et al. Allergic rhinitis , 2018, Allergy, Asthma & Clinical Immunology.
[39] G. Laekeman,et al. Doelmatige behandeling van allergische aandoeningen (rhinoconjunctivitis, astma, anafylaxie op hymenopteragif), anafylaxie en angio-oedeem , 2010 .
[40] G. Verleden,et al. The impact of concomitant rhinitis on asthma‐related quality of life and asthma control , 2010, Allergy.
[41] J. Bousquet,et al. Uncontrolled allergic rhinitis during treatment and its impact on quality of life: a cluster randomized trial. , 2010, The Journal of allergy and clinical immunology.
[42] Holger J Schünemann,et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. , 2010, The Journal of allergy and clinical immunology.
[43] M. Kogevinas,et al. Risk factors of new‐onset asthma in adults: a population‐based international cohort study , 2010, Allergy.
[44] G. Viegi,et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 * , 2008, Allergy.
[45] J. Bousquet,et al. Allergic rhinitis and its consequences on quality of sleep: An unexplored area. , 2006, Archives of internal medicine.
[46] D. Strachan,et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys , 2006, The Lancet.
[47] C. Bachert,et al. Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium , 2006, Allergy.
[48] Benjamin Eng,et al. Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective , 2006, Current medical research and opinion.
[49] S. Durham,et al. Prevalence and rate of diagnosis of allergic rhinitis in Europe , 2004, European Respiratory Journal.
[50] J. Bousquet,et al. Allergic Rhinitis and its Impact on Asthma (ARIA) , 2003 .
[51] P. Demoly,et al. ERASM, a pharmacoepidemiologic survey on management of intermittent allergic rhinitis in every day general medical practice in France , 2002, Allergy.
[52] S. Guerra,et al. Rhinitis as an independent risk factor for adult-onset asthma. , 2002, The Journal of allergy and clinical immunology.
[53] J. O'hanlon,et al. Seasonal allergic rhinitis and antihistamine effects on children's learning , 1992, European Neuropsychopharmacology.
[54] R. Settipane,et al. Allergic rhinitis , 2005, Rhinology and Anterior Skull Base Surgery.